MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Clinical trials for MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING trials appear
Sign up with your email to follow new studies for MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a new MS drug help you walk better and avoid falls?
Disease control Recruiting nowThis study tests whether the drug ublituximab can improve walking and reduce fall risk in people with relapsing multiple sclerosis. Twenty-five participants will receive the treatment for 48 weeks and have their walking, balance, and thinking skills checked before, during, and af…
Matched conditions: MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Phase: EARLY_PHASE1 • Sponsor: Georgia State University • Aim: Disease control
Last updated May 26, 2026 02:00 UTC
-
Could a broccoli compound slow brain disease? new trial launches in 300 patients
Disease control Recruiting nowThis study tests a supplement made from a compound found in broccoli (glucoraphanin) in 300 people with Parkinson's disease, relapsing-remitting multiple sclerosis, or certain childhood nerve and muscle diseases. The goal is to see if it can protect the brain and slow disease pro…
Matched conditions: MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Phase: NA • Sponsor: IRCCS Centro Neurolesi Bonino Pulejo • Aim: Disease control
Last updated May 19, 2026 11:48 UTC
-
New hope for early MS: Twice-Yearly infusion under study
Disease control Recruiting nowThis study tests the safety and effectiveness of Ublituximab (Briumvi) given twice a year for early relapsing multiple sclerosis. About 40 adults with mild disability will receive the drug and be monitored for about a year. Researchers will measure nerve damage markers in the blo…
Matched conditions: MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Phase: PHASE4 • Sponsor: Northwestern University • Aim: Disease control
Last updated May 06, 2026 16:15 UTC
-
Mind over matter: new combo therapy aims to boost balance and brain power in MS patients
Symptom relief Recruiting nowThis study tests a new combination of mental imagery (thinking about moving) and balance exercises for people with relapsing-remitting multiple sclerosis. The goal is to see if this approach improves balance, thinking skills, and quality of life. The trial will enroll 30 adults a…
Matched conditions: MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Phase: NA • Sponsor: Medipol University • Aim: Symptom relief
Last updated May 26, 2026 02:08 UTC
-
Vibrating sleeve could ease MS arm troubles
Symptom relief Recruiting nowThis small study is testing whether a wearable device that gently vibrates the arm muscles can help people with multiple sclerosis (MS) use their hands and arms better. Fifteen adults with relapsing-remitting MS will use the device at home for four weeks. The goal is to see if th…
Matched conditions: MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Phase: NA • Sponsor: University of Florida • Aim: Symptom relief
Last updated May 26, 2026 02:03 UTC
-
Simple home workouts may boost balance and brain power in MS
Symptom relief Recruiting nowThis study tests whether a home-based balance exercise program can improve both physical and cognitive symptoms in people with multiple sclerosis (MS). 75 adults with MS will be randomly assigned to either the balance program or a stretching routine for 4 months. All sessions are…
Matched conditions: MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Phase: NA • Sponsor: University of Illinois at Chicago • Aim: Symptom relief
Last updated May 19, 2026 11:46 UTC
-
Blood test may outsmart MRI in spotting silent MS Flare-Ups
Knowledge-focused Recruiting nowThis study compares monthly blood tests for a nerve damage marker (NfL) against standard yearly MRI scans in people with relapsing-remitting MS. The goal is to see if the blood test can catch hidden disease activity sooner, allowing faster treatment changes. About 84 participants…
Matched conditions: MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated May 26, 2026 02:10 UTC
-
Selfie videos could revolutionize MS monitoring
Knowledge-focused Recruiting nowThis study looks at whether short selfie videos taken on a smartphone can accurately measure walking and speech changes in people with multiple sclerosis (MS). About 300 adults with MS will record 5 videos every 3 months for a year and also visit the clinic for standard tests. Th…
Matched conditions: MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated May 26, 2026 02:07 UTC
-
Hidden struggle: MS and sexual dysfunction in women under the microscope
Knowledge-focused Recruiting nowThis study looks at how common sexual problems are in women with multiple sclerosis (MS) and how they connect to fatigue, depression, anxiety, bladder issues, and thinking problems. Researchers will survey 140 women with relapsing-remitting MS who have a regular partner and are s…
Matched conditions: MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Sponsor: Ege University • Aim: Knowledge-focused
Last updated May 26, 2026 02:06 UTC
-
Eye scans could reveal how MS drug works in real time
Knowledge-focused Recruiting nowThis study tests whether a special eye scan (OCT) can detect immune cell changes in people with relapsing-remitting multiple sclerosis (MS) who are starting the drug ublituximab (Briumvi). Researchers will compare 15 patients starting ublituximab with 15 stable MS patients not on…
Matched conditions: MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING
Phase: NA • Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated May 26, 2026 01:57 UTC